Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.

Mirzaei HR, Rodriguez A, Shepphird J, Brown CE, Badie B.

Front Immunol. 2019 Apr 17;10:780. doi: 10.3389/fimmu.2019.00780. eCollection 2019.

2.

A brainstem mass of Müllerian type Epithelial Origin without any primary cancer source.

Fiani B, Quadri SA, Farooqui M, D'Apuzzo M, Rosser RJ, Berman BW, Noel J, Xin XS, Badie B, Ramachandran A, Siddiqi J.

J Clin Neurosci. 2019 Jan;59:325-332. doi: 10.1016/j.jocn.2018.10.016. Epub 2018 Oct 15.

PMID:
30337125
3.

Pituitary metastasis: a rare condition.

Javanbakht A, D'Apuzzo M, Badie B, Salehian B.

Endocr Connect. 2018 Aug 23. pii: EC-18-0338. doi: 10.1530/EC-18-0338. [Epub ahead of print]

4.

S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth.

Gao H, Zhang IY, Zhang L, Song Y, Liu S, Ren H, Liu H, Zhou H, Su Y, Yang Y, Badie B.

Cancer Lett. 2018 Dec 28;439:91-100. doi: 10.1016/j.canlet.2018.07.034. Epub 2018 Aug 2.

5.

Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus among HIV Positive Patients in Tehran, Iran.

Najafi E, Rasoolinejad M, Majlesi F, Hadadi A, Banihashemian S, Najafi M, Badie BM, Kalantari S, Tayeri K, Mohammadinejad P, SeyedAlinaghi S.

Infect Disord Drug Targets. 2018 Jul 23. doi: 10.2174/1871526518666180723152715. [Epub ahead of print]

PMID:
30039766
6.

Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival.

Sahoo P, Frankel P, Ressler J, Gutova M, Annala AJ, Badie B, Portnow J, Aboody KS, D'Apuzzo M, Rockne RC.

Stem Cells Int. 2018 Mar 14;2018:5312426. doi: 10.1155/2018/5312426. eCollection 2018.

7.

Immunostimulatory CpG on Carbon Nanotubes Selectively Inhibits Migration of Brain Tumor Cells.

Alizadeh D, White EE, Sanchez TC, Liu S, Zhang L, Badie B, Berlin JM.

Bioconjug Chem. 2018 May 16;29(5):1659-1668. doi: 10.1021/acs.bioconjchem.8b00146. Epub 2018 Apr 2.

PMID:
29526082
8.

Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.

Mirzaei HR, Rodriguez A, Shepphird J, Brown CE, Badie B.

Front Immunol. 2017 Dec 22;8:1850. doi: 10.3389/fimmu.2017.01850. eCollection 2017. Review. Erratum in: Front Immunol. 2019 Apr 17;10:780.

9.

Relationship Among HIV-Related Stigma, Mental Health and Quality of life for HIV-Positive Patients in Tehran.

Rasoolinajad M, Abedinia N, Noorbala AA, Mohraz M, Badie BM, Hamad A, Sahebi L.

AIDS Behav. 2018 Dec;22(12):3773-3782. doi: 10.1007/s10461-017-2023-z.

PMID:
29297112
10.

Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.

Brown CE, Aguilar B, Starr R, Yang X, Chang WC, Weng L, Chang B, Sarkissian A, Brito A, Sanchez JF, Ostberg JR, D'Apuzzo M, Badie B, Barish ME, Forman SJ.

Mol Ther. 2018 Jan 3;26(1):31-44. doi: 10.1016/j.ymthe.2017.10.002. Epub 2017 Oct 5.

11.

Chimeric antigen receptor T-cell therapy for glioblastoma.

Rodriguez A, Brown C, Badie B.

Transl Res. 2017 Sep;187:93-102. doi: 10.1016/j.trsl.2017.07.003. Epub 2017 Jul 15. Review.

PMID:
28755873
12.

Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12.

Chung B, Esmaeili AA, Gopalakrishna-Pillai S, Murad JP, Andersen ES, Kumar Reddy N, Srinivasan G, Armstrong B, Chu C, Kim Y, Tong T, Waisman J, Yim JH, Badie B, Lee PP.

NPJ Breast Cancer. 2017 Mar 2;3:6. doi: 10.1038/s41523-017-0008-8. eCollection 2017.

13.

Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.

Keu KV, Witney TH, Yaghoubi S, Rosenberg J, Kurien A, Magnusson R, Williams J, Habte F, Wagner JR, Forman S, Brown C, Allen-Auerbach M, Czernin J, Tang W, Jensen MC, Badie B, Gambhir SS.

Sci Transl Med. 2017 Jan 18;9(373). pii: eaag2196. doi: 10.1126/scitranslmed.aag2196.

14.

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.

Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, Ostberg JR, Blanchard MS, Kilpatrick J, Simpson J, Kurien A, Priceman SJ, Wang X, Harshbarger TL, D'Apuzzo M, Ressler JA, Jensen MC, Barish ME, Chen M, Portnow J, Forman SJ, Badie B.

N Engl J Med. 2016 Dec 29;375(26):2561-9. doi: 10.1056/NEJMoa1610497.

15.

Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.

Portnow J, Synold TW, Badie B, Tirughana R, Lacey SF, D'Apuzzo M, Metz MZ, Najbauer J, Bedell V, Vo T, Gutova M, Frankel P, Chen M, Aboody KS.

Clin Cancer Res. 2017 Jun 15;23(12):2951-2960. doi: 10.1158/1078-0432.CCR-16-1518. Epub 2016 Dec 15.

16.

Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.

Zhang I, Alizadeh D, Liang J, Zhang L, Gao H, Song Y, Ren H, Ouyang M, Wu X, D'Apuzzo M, Badie B.

PLoS One. 2016 Dec 9;11(12):e0165118. doi: 10.1371/journal.pone.0165118. eCollection 2016.

17.

Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications.

Badie SM, Rasoulinejad M, Salehi MR, Kochak HE, Alinaghi SAS, Manshadi SAD, Abad FJA, Badie BM.

Infect Disord Drug Targets. 2017;17(1):43-51. doi: 10.2174/1871526516666161205124309.

PMID:
27919209
18.

Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.

Kanaya N, Somlo G, Wu J, Frankel P, Kai M, Liu X, Wu SV, Nguyen D, Chan N, Hsieh MY, Kirschenbaum M, Kruper L, Vito C, Badie B, Yim JH, Yuan Y, Hurria A, Peiguo C, Mortimer J, Chen S.

J Steroid Biochem Mol Biol. 2017 Jun;170:65-74. doi: 10.1016/j.jsbmb.2016.05.001. Epub 2016 May 3.

19.

Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.

Wheeler LA, Manzanera AG, Bell SD, Cavaliere R, McGregor JM, Grecula JC, Newton HB, Lo SS, Badie B, Portnow J, Teh BS, Trask TW, Baskin DS, New PZ, Aguilar LK, Aguilar-Cordova E, Chiocca EA.

Neuro Oncol. 2016 Aug;18(8):1137-45. doi: 10.1093/neuonc/now002. Epub 2016 Feb 2.

20.

Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis.

Cui Q, Yang S, Ye P, Tian E, Sun G, Zhou J, Sun G, Liu X, Chen C, Murai K, Zhao C, Azizian KT, Yang L, Warden C, Wu X, D'Apuzzo M, Brown C, Badie B, Peng L, Riggs AD, Rossi JJ, Shi Y.

Nat Commun. 2016 Feb 3;7:10637. doi: 10.1038/ncomms10637.

21.

Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.

Ouyang M, White EE, Ren H, Guo Q, Zhang I, Gao H, Yanyan S, Chen X, Weng Y, Da Fonseca A, Shah S, Manuel ER, Zhang L, Vonderfecht SL, Alizadeh D, Berlin JM, Badie B.

PLoS One. 2016 Feb 1;11(2):e0148139. doi: 10.1371/journal.pone.0148139. eCollection 2016.

22.

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.

Brown CE, Badie B, Barish ME, Weng L, Ostberg JR, Chang WC, Naranjo A, Starr R, Wagner J, Wright C, Zhai Y, Bading JR, Ressler JA, Portnow J, D'Apuzzo M, Forman SJ, Jensen MC.

Clin Cancer Res. 2015 Sep 15;21(18):4062-72. doi: 10.1158/1078-0432.CCR-15-0428. Epub 2015 Jun 9.

23.

Current and emerging treatments for brain metastases.

Lin J, Jandial R, Nesbit A, Badie B, Chen M.

Oncology (Williston Park). 2015 Apr;29(4):250-7. Review.

24.

Functionalized iron oxide nanoparticles for controlling the movement of immune cells.

White EE, Pai A, Weng Y, Suresh AK, Van Haute D, Pailevanian T, Alizadeh D, Hajimiri A, Badie B, Berlin JM.

Nanoscale. 2015 May 7;7(17):7780-9. doi: 10.1039/c3nr04421a.

25.

RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma.

Chen X, Zhang L, Zhang IY, Liang J, Wang H, Ouyang M, Wu S, da Fonseca ACC, Weng L, Yamamoto Y, Yamamoto H, Natarajan R, Badie B.

Cancer Res. 2014 Dec 15;74(24):7285-7297. doi: 10.1158/0008-5472.CAN-14-1240. Epub 2014 Oct 17.

26.

TLR9 is critical for glioma stem cell maintenance and targeting.

Herrmann A, Cherryholmes G, Schroeder A, Phallen J, Alizadeh D, Xin H, Wang T, Lee H, Lahtz C, Swiderski P, Armstrong B, Kowolik C, Gallia GL, Lim M, Brown C, Badie B, Forman S, Kortylewski M, Jove R, Yu H.

Cancer Res. 2014 Sep 15;74(18):5218-28. doi: 10.1158/0008-5472.CAN-14-1151. Epub 2014 Jul 21.

27.

Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages.

Carvalho da Fonseca AC, Wang H, Fan H, Chen X, Zhang I, Zhang L, Lima FR, Badie B.

J Neuroimmunol. 2014 Sep 15;274(1-2):71-7. doi: 10.1016/j.jneuroim.2014.06.021. Epub 2014 Jun 27.

28.

A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent.

Portnow J, Badie B, Liu X, Frankel P, Mi S, Chen M, Synold TW.

J Neurooncol. 2014 May;118(1):169-77. doi: 10.1007/s11060-014-1415-4. Epub 2014 Mar 15.

29.

Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis.

Brown CE, Warden CD, Starr R, Deng X, Badie B, Yuan YC, Forman SJ, Barish ME.

PLoS One. 2013 Oct 18;8(10):e77769. doi: 10.1371/journal.pone.0077769. eCollection 2013. Erratum in: PLoS One. 2018 Sep 17;13(9):e0204463.

30.

Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.

Anderson BM, Khuntia D, Bentzen SM, Geye HM, Hayes LL, Kuo JS, Baskaya MK, Badie B, Basavatia A, Pyle GM, Tomé WA, Mehta MP.

J Neurooncol. 2014 Jan;116(1):187-93. doi: 10.1007/s11060-013-1282-4. Epub 2013 Oct 20.

PMID:
24142200
31.

Early loss to follow-up and mortality of HIV-infected patients diagnosed after the era of antiretroviral treatment scale up: a call for re-invigorating the response in Iran.

Badie BM, Nabaei G, Rasoolinejad M, Mirzazadeh A, McFarland W.

Int J STD AIDS. 2013 Dec;24(12):926-30. doi: 10.1177/0956462413491733. Epub 2013 Aug 6.

PMID:
23970628
32.

Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies.

da Fonseca AC, Badie B.

Clin Dev Immunol. 2013;2013:264124. doi: 10.1155/2013/264124. Epub 2013 Jun 25. Review.

33.

Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.

Kim DH, Schultheiss TE, Radany EH, Badie B, Pezner RD.

J Neurooncol. 2013 Oct;115(1):37-43. doi: 10.1007/s11060-013-1191-6. Epub 2013 Jun 28.

PMID:
23813230
34.

S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.

Wang H, Zhang L, Zhang IY, Chen X, Da Fonseca A, Wu S, Ren H, Badie S, Sadeghi S, Ouyang M, Warden CD, Badie B.

Clin Cancer Res. 2013 Jul 15;19(14):3764-75. doi: 10.1158/1078-0432.CCR-12-3725. Epub 2013 May 29.

35.

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

Aboody KS, Najbauer J, Metz MZ, D'Apuzzo M, Gutova M, Annala AJ, Synold TW, Couture LA, Blanchard S, Moats RA, Garcia E, Aramburo S, Valenzuela VV, Frank RT, Barish ME, Brown CE, Kim SU, Badie B, Portnow J.

Sci Transl Med. 2013 May 8;5(184):184ra59. doi: 10.1126/scitranslmed.3005365.

36.

A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas.

Portnow J, Badie B, Markel S, Liu A, D'Apuzzo M, Frankel P, Jandial R, Synold TW.

Eur J Cancer. 2013 May;49(7):1634-40. doi: 10.1016/j.ejca.2013.01.001. Epub 2013 Feb 4.

37.

The future of CpG immunotherapy in cancer.

Badie B, Berlin JM.

Immunotherapy. 2013 Jan;5(1):1-3. doi: 10.2217/imt.12.148. No abstract available.

38.

Monocyte-derived cells of the brain and malignant gliomas: the double face of Janus.

Kushchayev SV, Kushchayeva YS, Wiener PC, Scheck AC, Badie B, Preul MC.

World Neurosurg. 2014 Dec;82(6):1171-86. doi: 10.1016/j.wneu.2012.11.059. Epub 2012 Nov 23.

PMID:
23178919
39.

Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice.

Fan H, Zhang I, Chen X, Zhang L, Wang H, Da Fonseca A, Manuel ER, Diamond DJ, Raubitschek A, Badie B.

Clin Cancer Res. 2012 Oct 15;18(20):5628-38. doi: 10.1158/1078-0432.CCR-12-1911. Epub 2012 Aug 17.

40.

Incidence of isolation of Mycobacterium tuberculosis from blood samples in tuberculosis patients in Imam Khomeini Hospital, Tehran, Iran.

Foroughi M, Montazeri SM, SeyedAlinaghi S, Badie BM, Heiydarpour P, Roosta N, Rasoolinejad M, Cochak HE.

Acta Med Iran. 2011;49(8):556-9.

41.

Evaluation of bone mineral density in Iranian HIV/AIDS patients.

Badie BM, Soori T, Kheirandish P, Izadyar S, SeyedAlinagh S, Foroughi M, Rostamian A, Mohraz M.

Acta Med Iran. 2011;49(7):460-7.

42.

FNA diagnostic value in patients with neck masses in two teaching hospitals in Iran.

Saatian M, Badie BM, Shahriari S, Fattahi F, Rasoolinejad M.

Acta Med Iran. 2011;49(2):85-8.

43.

S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway.

Zhang L, Liu W, Alizadeh D, Zhao D, Farrukh O, Lin J, Badie SA, Badie B.

Glia. 2011 Mar;59(3):486-98. doi: 10.1002/glia.21118. Epub 2010 Dec 29.

44.

Respiratory Complications in Iranian Hospitalized Patients with HIV/AIDS.

Alinaghi SA, Vaghari B, Roham M, Badie BM, Jam S, Foroughi M, Djavid GE, Hajiabdolbaghi M, Hosseini M, Mohraz M, McFarland W.

Tanaffos. 2011;10(3):49-54.

45.

Adverse reactions of trivalent influenza vaccine in HIV-infected individuals.

Hajiabdolbaghi M, Jam S, SeyedAlinaghi S, Jafari S, Badie BM, Sabzvari D.

Acta Med Iran. 2010 Mar-Apr;48(2):95-100.

46.

Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity.

Zhao D, Alizadeh D, Zhang L, Liu W, Farrukh O, Manuel E, Diamond DJ, Badie B.

Clin Cancer Res. 2011 Feb 15;17(4):771-82. doi: 10.1158/1078-0432.CCR-10-2444. Epub 2010 Nov 18.

47.

Multi-walled carbon nanotube (MWCNT) synthesis, preparation, labeling, and functionalization.

Kateb B, Yamamoto V, Alizadeh D, Zhang L, Manohara HM, Bronikowski MJ, Badie B.

Methods Mol Biol. 2010;651:307-17. doi: 10.1007/978-1-60761-786-0_18.

PMID:
20686974
48.

Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy.

Alizadeh D, Zhang L, Brown CE, Farrukh O, Jensen MC, Badie B.

Clin Cancer Res. 2010 Jul 1;16(13):3399-408. doi: 10.1158/1078-0432.CCR-09-3087. Epub 2010 Jun 22.

49.

Carbon nanotube uptake and toxicity in the brain.

Zhang L, Alizadeh D, Badie B.

Methods Mol Biol. 2010;625:55-65. doi: 10.1007/978-1-60761-579-8_6.

PMID:
20422381
50.

Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, Shih CC, Badie B, Hudecek M, Riddell SR, Jensen MC.

Cancer Res. 2009 Dec 1;69(23):8886-93. doi: 10.1158/0008-5472.CAN-09-2687. Epub 2009 Nov 10.

Supplemental Content

Support Center